A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship
NCT ID: NCT07013435
Last Updated: 2025-06-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
254 participants
INTERVENTIONAL
2026-01-31
2030-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors
NCT07014293
Building Resiliency Among Caregivers of Curvivors and Metavivors
NCT05702723
A Stress Management and Resiliency Program for Adolescent and Young Adult Survivors
NCT03768336
Promoting Resiliency Among Lymphoma Survivors: The 3RP-Lymphoma
NCT03212261
Real-Life Pilot Feasibility Study (LC_RLP)
NCT05797727
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The main questions it aims to answer are:
* Will survivors randomized to SMART3RP-Lymphoma demonstrate greater improvements in quality of life when compared to survivors randomized to a Health Education Program?
* Will improvements in resiliency lead to improvements in quality of life?
To answer these questions, researchers will compare a resilience intervention tailored to the needs of lymphoma survivors (SMART3RP-Lymphoma) to a Health Education Program to see how they affect quality of life of lymphoma survivors.
Participants will:
* Fill out 4 surveys across 12 months
* Participate in 8 weekly, virtual group sessions
* Submit hair cortisol samples
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Health Education Program
Participants will participate in 8 weekly sessions.
Components include:
* education on the co-occurrence of mental and physical problems
* goal setting for health behavior change
* self-monitoring
HEP is an active control condition for mind body programs and is structurally equivalent to SMART3RP
Health Education Program
8 weekly sessions that include education on the co-occurrence of mental and physical problems, goal setting for health behavior change, and self-monitoring. Each session includes basic didactic information, interactive application of the information, and open discussion of didactic material.
SMART3RP-Lymphoma
Participants will participate in 8 weekly sessions.
The intervention components include:
* Eliciting the relaxation response (RR),
* CBT strategies to improve stress management
* Positive psychology strategies to achieve growth enhancement
SMART3RP-Lymphoma
The SMART3RP-lymphoma is a group program that, through a variety of mind-body approaches, such as imagery, relaxation, and yoga, seeks to buffer stress and promote psychological resiliency and physical well-being.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Health Education Program
8 weekly sessions that include education on the co-occurrence of mental and physical problems, goal setting for health behavior change, and self-monitoring. Each session includes basic didactic information, interactive application of the information, and open discussion of didactic material.
SMART3RP-Lymphoma
The SMART3RP-lymphoma is a group program that, through a variety of mind-body approaches, such as imagery, relaxation, and yoga, seeks to buffer stress and promote psychological resiliency and physical well-being.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Within 2 years of completing active, curative treatment for lymphoma (includes surgery, chemotherapy, immunotherapy, radiation therapy, or other)
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Massachusetts General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Giselle K. Perez Lougee
Clinical Psychologist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mass General Hospital
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
25-204
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.